PRESS RELEASE published on 09/25/2026 at 07:30, 1 month 26 days ago CROSSJECT publie ses résultats du premier semestre 2026 et présente une structure financière profondément renforcée CROSSJECT publie ses résultats du premier semestre 2026 avec une forte augmentation de trésorerie et des capitaux propres. Facturation BARDA de 2,5 M€, réduction de l'endettement à 7,8 M€ Résultats Trésorerie Endettement Crossject BARDA
PRESS RELEASE published on 09/25/2026 at 07:30, 1 month 26 days ago CROSSJECT strengthens its governance for the industrial and commercial deployment phase CROSSJECT expands governance with appointment of new Executive Board members to focus on industrial and commercial deployment phase Governance Executive Board Commercial Deployment Crossject Industrial Deployment
PRESS RELEASE published on 09/25/2026 at 07:30, 1 month 26 days ago CROSSJECT structure sa gouvernance pour la phase de déploiement industriel et commercial CROSSJECT restructure son Directoire pour la phase de déploiement industriel et commercial. Gouvernance renforcée avec 3 nouvelles nominations clés Nominations Restructuration Déploiement Industriel Crossject Directoire
BRIEF published on 03/25/2026 at 07:25, 7 months 27 days ago Les résultats financiers de CROSSJECT pour 2025 indiquent une trajectoire positive. ZEPIZURE® Résultats Financiers 2025 Financement De La BARDA Plateforme ZENEO® Stratégie CROSSJET
BRIEF published on 03/25/2026 at 07:25, 7 months 27 days ago CROSSJECT's 2025 Financial Results Indicate Positive Trajectory BARDA Funding ZEPIZURE® Financial Results 2025 ZENEO® Platform CROSSJECT Strategy
PRESS RELEASE published on 03/25/2026 at 07:20, 7 months 27 days ago CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory CROSSJECT publishes its 2025 financial results, showing improved operating revenue and net loss. Strengthening operational, industrial, and financial trajectory highlighted for ZEPIZURE® and ZENEO® platform development Financial Results Net Loss Operating Revenue Crossject ZEPIZURE®
BRIEF published on 11/14/2025 at 20:51, 1 year ago CROSSJECT finalise un accord de financement de 5 millions d'euros avec Vatel Capital Obligations Convertibles ZEPIZURE® Financement De 5 Millions D'euros CROSSJET Capitale Vatel
BRIEF published on 11/14/2025 at 20:51, 1 year ago CROSSJECT Completes €5 Million Financing Deal with Vatel Capital Convertible Bonds Crossject ZEPIZURE® Vatel Capital €5 Million Financing
PRESS RELEASE published on 11/14/2025 at 20:46, 1 year ago CROSSJECT completes €5 million financing with Vatel Capital CROSSJECT announces completion of €5 million financing with Vatel Capital through convertible bonds for ZEPIZURE® development. Funds to support regulatory activities for emergency use authorization application Financing Convertible Bonds Crossject ZEPIZURE® Vatel Capital
PRESS RELEASE published on 11/14/2025 at 20:46, 1 year ago CROSSJECT lève 5 millions d'euros auprès de Vatel Capital CROSSJECT lève 5 millions d'euros auprès de Vatel Capital pour son auto-injecteur ZENEO et injectable ZEPIZURE. Opération de 3 tranches d'Obligations Convertibles avec intérêts de 7,5% à 9,5% sur 3 à 5 ans Obligations Convertibles Crossject ZEPIZURE ZENEO Vatel Capital
Published on 11/20/2026 at 15:00, 1 day 7 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 8 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 8 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 9 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 9 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 23 hours 4 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 1 hour ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 2 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 1 day 4 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 1 day 4 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 5 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 1 day 5 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 3 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR